GlobeNewswire Inc.·18h ago·NaAlamar Biosciences Posts Record Q1 Revenue as IPO Fuels Growth StrategyAlamar Biosciences reported record Q1 2026 revenue of $26.0M, nearly doubling year-over-year following April IPO that raised $197.8M. ALMRIPOnet loss
GlobeNewswire Inc.··Na